Document Detail


Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
MedLine Citation:
PMID:  7623237     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Infants with neuroblastoma are known to have a better prognosis than older children. In Japan in 1985, mass screening for neuroblastoma in infants aged 6 months was introduced. With this policy, there has been an increase in the number of patients seen with neuroblastoma between 6 and 11 months of age. In a previous report the authors described the management and prognosis of infants with disease detected by mass screening, but there is still little information regarding the strategies of management for infants with neuroblastoma aged less than 6 months. The authors analyzed the data regarding 27 patients aged less than 6 months registered in their region (population 15 million) from 1985 to 1992, and compared it with that of the previous 8-year period. In the younger age group, there was a significantly higher rate of advanced disease stages (III and IV). In spite of the variation in treatment related to the choice of individual institutions, infants with stages I, II, and III disease had a good outcome, suggesting that aggressive chemotherapy is not necessary unless poor prognostic factors are present. One patient with stage IV disease died of disseminated disease and one with stage IVs and 22 copies of N-myc oncogene also died of tumor relapse in spite of aggressive chemotherapy. It is therefore concluded that the prognosis in infants with stage IV and IVs neuroblastoma under the age of 6 months is not as good as had previously been believed, and that such patients, therefore, require special consideration.
Authors:
S Suita; Y Zaizen; Y Sera; H Takamatsu; H Mizote; H Ogami; N Kurosaki; K Ueda; H Tasaka; S Miyazaki
Related Documents :
7874527 - Keeping phenylketonuria under control.
12872837 - Evaluation of 3-methylcrotonyl-coa carboxylase deficiency detected by tandem mass spect...
24732057 - Topical amphotericin b in combination with standard therapy for severe necrotizing skin...
19385487 - Benefit and pitfalls of newborn hearing screening.
17292647 - The effect of codeine on the urge-to-cough response to inhaled capsaicin.
16522927 - Growth, tolerance and biochemical measures in healthy infants fed a partially hydrolyze...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pediatric surgery     Volume:  30     ISSN:  0022-3468     ISO Abbreviation:  J. Pediatr. Surg.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-08-31     Completed Date:  1995-08-31     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  0052631     Medline TA:  J Pediatr Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  715-21     Citation Subset:  IM    
Affiliation:
Department of Pediatric Surgery, Kyushu University, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Female
Ganglioneuroblastoma / drug therapy,  mortality,  pathology,  therapy*
Homovanillic Acid / urine
Humans
Infant
Male
Neuroblastoma / drug therapy,  mortality,  pathology,  therapy*
Prognosis
Survival Rate
Tumor Markers, Biological
Vanilmandelic Acid / urine
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological; 306-08-1/Homovanillic Acid; 55-10-7/Vanilmandelic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Valve replacement for children: report of two cases.
Next Document:  Biological characteristics of neuroblastoma with spontaneous tumor reduction: a case report.